Tarsus Appoints Scott Morrison as Board Member and Audit Committee Chair
Mr. Morrison brings over 40 years of financial and operational expertise in life sciences IRVINE,…
Month: October 2022
GT Biopharma Announces Two Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
BRISBANE, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) — GT Biopharma, Inc. (the “Company” or “GTB”)…
Oncotelic Announces Formation of Animal Health Division
AGOURA HILLS, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc (OTCQB:OTLC) (“Oncotelic”, the…
Opiant Pharmaceuticals Announces Completion of Enrollment in Phase 2 Clinical Trial of OPNT002, Nasal Naltrexone, in Patients with Alcohol Use Disorder
SANTA MONICA, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (Opiant) (NASDAQ: OPNT), a…
Ocugen, Inc. to Present at Upcoming Vaccines, Cell & Gene Therapy Conferences
MALVERN, Pa., Oct. 06, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ:…
Celularity Promotes Two Executives in Executive Leadership Team
FLORHAM PARK, N.J., Oct. 06, 2022 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a…
Aruna Bio Announces Presentation on Neural Exosome Treatment Opportunities and Lead Program, AB126 at Exosome Based Therapeutic Development Summit
-AB126 is an unmodified exosome derived from neural stem cell lines with the innate ability…
Cabaletta Bio to Present at the 29th Annual Congress of the European Society of Gene & Cell Therapy
PHILADELPHIA, Oct. 06, 2022 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology…
Cyclerion Announces Mitochondrial Disease-Focused Corporate Strategy
Recent positive MELAS clinical study data drive urgency to deliver potential first-ever therapy for patients…
Tempest to Present at Emerging Technologies for IO Targeting and Discovery Summit
Dara Burdette, Ph.D., Tempest Senior Director of Discovery Research, to Chair “New Approaches to Solid…
TRACON Pharmaceuticals Announces Results of Independent Data Monitoring Committee Review of 12 Week Safety Data from ENVASARC Phase 2 Pivotal Trial – Trial to Proceed as Planned
Review of Interim Efficacy Data by IDMC to Occur in Fourth Quarter SAN DIEGO, Oct….
Paladin Phase 4 Study Confirms ILUVIEN® Patients’ Reduced Need for Multiple Treatments
Data from the Phase 4 observational real-world safety study of the intravitreal implant were presented…
Axial Therapeutics to Present at BioJapan Conference
WOBURN, Mass., Oct. 06, 2022 (GLOBE NEWSWIRE) — Axial Therapeutics Inc., a clinical-stage biopharmaceutical company…
Surrozen Announces Strategic Partnership with Boehringer Ingelheim to Develop Wnt Agonist SZN-413 for People with Retinal Diseases
The collaboration and licensing agreement is Surrozen’s first strategic partnership for one of its compounds…
Enzo Biochem, Inc. Opens Expanded Life Sciences Laboratory and Office Facilities in Farmingdale, New York
100,000 square foot facility to support company plans for growth in clinical laboratory services, drug…
Rackspace Technology Highlights Evolution of Cloud Security for National Cybersecurity Awareness Month
With threat landscape evolving at a rapid pace, modernizing security needs to be a key component…
Panbela to Participate in the Roth Inaugural Healthcare Opportunities Conference
MINNEAPOLIS, Oct. 06, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
Augmentt Deepens SaaS Security with SOC 2 Type 2 Compliance
Augmentt Secure Premium also includes new features and functionality that make it easier for MSPs…
Innovation Passport Granted for CRN04777 for the Treatment of Congenital Hyperinsulinism
SAN DIEGO, Oct. 06, 2022 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced…
Todos Medical Announces Successful Pilot Launch of Suite of PCR Testing Services by CLIA/CAP Lab Provista Diagnostics
Rural FL launch serves as proof of concept for underserved regions nationally NEW YORK, NY…